LRRK2 and inflammatory bowel disease: Less common LRRK2 missense mutations also modulate kinase activity of LRRK2 by varying amounts (22–24); these represent but a few of the almost 100 known LRRK2 mutations, some of which also modulate risk of a form of inflammatory bowel disease and a form of leprosy (25).